Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
MG Bubnova - CardioSomatics, 2022 - cardiosomatics.orscience.ru
The article aims to systematize the available data on the current use of statins and calcium
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
MG Bubnova - CardioSomatics, 2022 - journals.eco-vector.com
The article aims to systematize the available data on the current use of statins and calcium
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
MG Bubnova - CardioSomatics, 2022 - journals.rcsi.science
The article aims to systematize the available data on the current use of statins and calcium
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
[HTML][HTML] Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
MG Bubnova - CardioSomatics, 2022 - cardiosomatics.ru
The article aims to systematize the available data on the current use of statins and calcium
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
MG Bubnova - CardioSomatics, 2022 - cardiosomatics.orscience.ru
The article aims to systematize the available data on the current use of statins and calcium
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …
channel antagonists (CA) for cardiovascular disorders therapy and to analyze the results of …